Industry News
Unitree Files $610M Shanghai IPO as Humanoid Revenue Crosses 50%
Unitree Robotics filed for a $610 million IPO on Shanghai's STAR Market, making it the first company where humanoid robots account for the majority of revenue to seek a public listing. With 5,500 humanoids shipped in 2025 and a 20,000-unit target for 2026, the filing gives investors their first real look at humanoid robotics unit economics.
Unitree Robotics filed for an initial public offering on the Shanghai Stock Exchange on Friday, seeking to raise 4.2 billion yuan (roughly $610 million) on the STAR Market. The Hangzhou-based company, which shipped over 5,500 humanoid robots in 2025, is testing whether China's public markets have the appetite for a pure-play humanoid robotics listing at a moment when the sector is flush with private capital but thin on profits.
Half of the IPO proceeds will fund AI model development for robot "brains," while a quarter will go toward expanding manufacturing capacity. Unitree plans to ship 20,000 humanoid units in 2026, nearly four times its 2025 output. If the listing succeeds, it would rank among the largest robotics IPOs globally and signal that humanoid robots have crossed from venture-stage curiosity to investable public equity.
Key Stats
$610M
IPO Target Raise
5,500+
Humanoids Shipped (2025)
335%
Revenue Growth YoY
20,000
2026 Shipment Target
What the Filing Reveals
Unitree's IPO prospectus, filed with the Shanghai Stock Exchange's STAR Market (China's Nasdaq equivalent for tech companies), lays out a company growing at breakneck speed but still navigating the gap between hardware shipments and sustained profitability. Revenue for the first nine months of 2025 hit 1.2 billion yuan (approximately $170 million), with full-year revenue growing 335% year-over-year. Net profit for 2025 is estimated at roughly 288 million yuan ($40 million), more than double the prior year.
The company plans to allocate IPO funds across three buckets: about 2.1 billion yuan for AI research (including foundation models for robot perception and manipulation), roughly 1 billion yuan for factory expansion, and the remainder for working capital. That R&D-heavy split reflects a bet that the competitive moat in humanoid robotics will be software, not just hardware.
Humanoid robots already account for more than 51% of Unitree's total revenue, a shift from its origins as a quadruped robot maker (the Go1 and Go2 "robot dogs" were its early hits). The G1, priced at $13,500 per unit, has become the volume driver. The higher-end H1, at roughly $90,000, targets research labs and enterprise customers needing more payload capacity and speed.
Key Insight
Unitree's IPO would be the first major public listing of a company where humanoid robots make up the majority of revenue. Previous robotics IPOs (like UiPath or Symbotic) focused on software or warehouse automation. This is a pure hardware-plus-AI play, and its reception will set the tone for other humanoid companies eyeing public markets.
Under the Hood: Unitree's Product Lineup
Unitree's humanoid portfolio spans two distinct price points and use cases. The G1 is the company's volume play: a 1.32-meter tall, 35-kilogram bipedal robot with 23 degrees of freedom (up to 43 in the EDU variant). It runs on a 9,000 mAh quick-swap battery lasting roughly two hours, carries up to 3 kilograms per arm, and costs $13,500 at the base configuration. The EDU version adds a Jetson Orin compute module and optional three-fingered dexterous hands.
The H1 sits at the premium end. Standing 1.8 meters tall and weighing 47 kilograms (70 kilograms for the H1-2 variant), it holds the world speed record for bipedal walking at 3.3 meters per second. With 27 degrees of freedom, a 360 N·m peak joint torque, and a 15 Ah battery pack, the H1 is built for industrial environments where payload and agility matter more than price.
AI-generated image
Unitree plans to use IPO proceeds to expand manufacturing capacity for its humanoid robot lineup.
| Spec | Unitree G1 | Unitree H1 | Figure 03 | Tesla Optimus Gen 3 |
|---|---|---|---|---|
| Height | 1.32 m | 1.80 m | ~1.65 m | 1.73 m |
| Weight | 35 kg | 47 kg | ~60 kg | ~57 kg |
| DOF | 23–43 | 27 | 65+ | ~30 |
| Max Joint Torque | 120 N·m | 360 N·m | Not disclosed | Not disclosed |
| Battery Life | ~2 hrs | ~2 hrs | ~4 hrs | ~2–4 hrs |
| Price | $13,500 | ~$90,000 | ~$20,000 (lease) | $20,000–$30,000 |
| Status | Shipping | Shipping | Pre-production | Low-volume 2026 |
Who Unitree Is Up Against
Unitree's IPO lands in the middle of a global spending spree on humanoid robots. Apptronik raised $520 million in February at a $5 billion valuation. Figure AI is running its Figure 03 through home and factory trials. Tesla plans low-volume Optimus Gen 3 production this summer with a target of 500,000 units by 2027. Boston Dynamics started production of its electric Atlas for Hyundai deployments. And 1X Technologies is accepting pre-orders for its NEO home robot at $20,000.
What separates Unitree from most of these competitors is that it is already shipping at scale. With 5,500 humanoid units delivered in 2025, it claims the top spot globally for humanoid robot shipments. The G1's $13,500 price point undercuts every Western competitor by a wide margin. That price advantage comes from China's mature supply chain for electric motors, battery packs, and precision machining, the same ecosystem that made the country dominant in drones and electric vehicles.
🏭 Manufacturing Edge
Unitree benefits from China's deep supply chains for PMSM motors, lithium batteries, and precision bearings. The G1's $13,500 price is 30-50% below comparable Western humanoids.
📊 Volume Lead
5,500+ humanoid shipments in 2025 puts Unitree ahead of every competitor. Scale generates real-world data that feeds back into AI training, creating a compounding advantage.
The risk for Unitree is geopolitics. U.S. restrictions on advanced chip exports to China could limit access to the GPUs needed for AI model training. The company currently uses Intel processors and NVIDIA Jetson modules in its robots, both of which face potential export controls. The IPO filing acknowledges this risk but offers no specific mitigation plan beyond "domestic alternatives."
What This Means for the Humanoid Market
A successful Unitree IPO would do several things at once. It would validate the idea that humanoid robotics companies can reach public-market scale, not just attract venture dollars. It would give investors a liquid benchmark for pricing the sector. And it would put pressure on Western competitors to demonstrate similar revenue traction or risk losing the narrative to a Chinese company that's already profitable.
AI-generated image
Half of Unitree's IPO proceeds will fund AI model development for next-generation robot perception systems.
The timing is deliberate. China's government has designated humanoid robots as a strategic technology, with provinces like Jiangsu and Guangdong launching dedicated robotics development zones. Beijing's E-Town district recently scaled its humanoid robot production platform to 1,000 units. The UBTech-Siemens partnership announced this month targets 10,000 annual units by the end of 2026. Unitree's IPO fits into a national push to make China the world's largest producer of humanoid robots, not just the largest consumer.
For investors, the filing offers a rare look at actual humanoid robotics financials. Most competitors are private. Seeing Unitree's margins, R&D spend, and unit economics in a public prospectus will help the market calibrate expectations for companies like Figure AI and Apptronik, which may pursue their own IPOs in 2027 or 2028.
Risk Factors
• Chip export controls: U.S. restrictions on NVIDIA and Intel components could constrain Unitree's AI development and onboard compute options.
• Profitability at scale: Net margins are thin (estimated ~17% in 2025). Quadrupling production to 20,000 units will test whether costs scale down or quality issues scale up.
• Market timing: The STAR Market has been volatile for tech IPOs. A weak debut could cool investor enthusiasm across the entire humanoid sector.
• Western market access: Trade tensions and security concerns may limit Unitree's ability to sell directly in the U.S. and EU.
Frequently Asked Questions
When will Unitree actually start trading?
The IPO application was accepted on March 20, 2026. The CSRC approved Unitree's IPO registration on July 1, and Unitree priced the offering on August 6 at RMB 150.80 per share. Investor subscriptions are scheduled for August 10. As of Biped.News's August 8 verification, a first-trading date had not yet been confirmed in the official approval or current offering reports reviewed for the update.
Can U.S. investors buy Unitree stock?
The STAR Market is accessible to foreign institutional investors through the Stock Connect program linking Shanghai with Hong Kong. Retail U.S. investors would need a brokerage that supports Shanghai-Hong Kong Stock Connect, or they could gain exposure through ETFs that track Chinese tech or robotics indices.
How does Unitree's G1 compare to Tesla Optimus on price?
The G1 starts at $13,500, while Tesla's Optimus Gen 3 is projected at $20,000 to $30,000. The G1 is shorter (1.32 m vs 1.73 m) and lighter (35 kg vs ~57 kg), with fewer degrees of freedom in the base model. The price gap reflects both China's manufacturing cost advantages and different target markets: the G1 is aimed at education and light commercial use, while Optimus targets factory labor.
Is Unitree profitable?
Yes, at least on a net income basis. The company reported roughly 288 million yuan ($40 million) in estimated net profit for 2025, on revenue that grew 335% year-over-year. The first nine months of 2025 showed 105 million yuan in net profit on 1.2 billion yuan in revenue. These are modest margins, but they are margins, which is more than most humanoid robot companies can claim.
The 6-Month Outlook
Unitree's IPO filing marks a turning point for the humanoid robotics industry. For the first time, a company that derives most of its revenue from bipedal robots is opening its books to public scrutiny. The numbers are real: 5,500 units shipped, 335% revenue growth, positive net income. Whether the market rewards those numbers at a premium valuation will depend on investor confidence in the 20,000-unit 2026 production target and the company's ability to keep margins stable while scaling.
Two of those filing-stage milestones have now resolved: regulators approved the registration and Unitree set the offer price. The next checkpoints are the August 10 subscription process, a confirmed first-trading date, opening-market performance, and post-listing disclosures that show whether humanoid revenue growth can absorb rising R&D and commercialization costs.
The Bottom Line: Unitree's $610 million IPO filing is the first real test of whether public markets will buy the humanoid robot thesis, and at 5,500 units shipped and 335% revenue growth, it has a stronger case than anyone expected a year ago.
The humanoid robotics sector has spent the last two years running on private capital and promises. Unitree is about to find out what happens when the spreadsheets go public.